Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Tenax Therapeutics (TENX) Other Operating Expenses (2016)

Tenax Therapeutics' Other Operating Expenses history spans 6 years, with the latest figure at $33.3 million for Q4 2016.

  • For Q4 2016, Other Operating Expenses changed N/A year-over-year to $33.3 million; the TTM value through Sep 2017 reached $33.3 million, up 310.38%, while the annual FY2016 figure was $33.3 million, N/A changed from the prior year.
  • Other Operating Expenses for Q4 2016 was $33.3 million at Tenax Therapeutics, up from -$23.7 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $96.5 million in Q2 2014 and bottomed at -$140.2 million in Q4 2012.
  • The 5-year median for Other Operating Expenses is $14.1 million (2012), against an average of $10.4 million.
  • The largest YoY upside for Other Operating Expenses was 6618.94% in 2012 against a maximum downside of 42066.06% in 2012.
  • A 5-year view of Other Operating Expenses shows it stood at -$140.2 million in 2012, then surged by 97.13% to -$4.0 million in 2013, then surged by 2498.91% to $96.5 million in 2014, then crashed by 98.93% to $1.0 million in 2015, then skyrocketed by 3114.44% to $33.3 million in 2016.
  • Per Business Quant, the three most recent readings for TENX's Other Operating Expenses are $33.3 million (Q4 2016), -$23.7 million (Q3 2016), and $7.9 million (Q2 2016).